By Mike Capone, COO, Medidata Solutions
Digital biomarkers generated from mHealth tools are a fairly new concept in clinical trials, but the industry is evolving quickly.
By Raj Bhavsar, CTO, ConnectYourCare
It is hard to believe that just ten years ago, our world revolved around paper—especially in the world of health care. Thanks to rapid technological advances, our world has vastly changed.
By Brian Jacobs, MD, VP, CMIO & CIO, Children’s National Health System
The notion that we as healthcare providers should anticipate the needs of patients and act on the latest data might seem self-evident.
By Dan Dodson, System Director, IT Innovation, UNC Health Care
I started my career in healthcare but quickly took a detour and spent the majority of my work-life in the wireless industry before transitioning back, into digital healthcare.
By Paul Blake, Associate Director, GEP Worldwide
To re-imagine what is possible, without the limits that the status-quo imposes, and to work out how best to use our intellect and creativity
By Susan Hawkins, SVP, Population Health, Henry Ford Health System
In today’s national landscape, healthcare organizations are being pressured by consumers and purchasers to compete on value: high quality health outcomes, excellent experiences, and lower costs.
By Shola Oyewole, CIO, United Therapeutics Corporation
I am an information systems professional of 30 years, having worked in several industries including technology, education, non-profit, government, news media, and consulting.
By Deborah Profit, PhD, Leader, Otsuka Information Technology (OIT), Otsuka Pharmaceutical Development & Commercialization
The healthcare industry, since outset, has been home to some of the most cutting-edge and forward-looking science, whether in biology, chemistry or genetics.
By Ajay Shah, Director, Research Informatics and Systems Division, City of Hope
Top ten highest grossing drugs in the US help between 25 to 40 percent people who take them. Precision Medicine (PM) approach promises better-informed, stratified and personalized patient care decisions and therapeutic discoveries.
By Cynthia A. Challener, Ph.D., Scientific Content Director, That’s Nice LLC
Evaluation of the safety and efficacy of new medicines is a crucial component of the drug development process, but one that has become increasingly complex and costly.